BioSig Technologies, Inc. STEX Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s operating income?
- BioSig Technologies, Inc. (STEX) reported operating income of -$35.75M in Q1 2026.
- How has BioSig Technologies, Inc.'s operating income changed year-over-year?
- BioSig Technologies, Inc.'s operating income decreased by 1097.9% year-over-year, from -$2.98M to -$35.75M.
- What is the long-term trend for BioSig Technologies, Inc.'s operating income?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s operating income has grown at a 20.8% compound annual growth rate (CAGR), from -$33.41M to -$71.1M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.